Novartis Shs Sponsored American Deposit Receipt Repr 1 Sh $89.02

down -0.24


23/7/2014 04:02 PM  |  NYSE : NVS  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get NVS Trend Analysis - it has outperformed the S&P 500 by 5%

Partner Headlines

  1. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD
  2. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD
  3. 5 New Medical Technologies For Diabetics

    Benzinga
  4. Novartis Joins Google To Develop Contacts For Diabetics

    Benzinga
  5. #PreMarket Primer: Friday, July 18: Tension Between Russia And The West ...

    Benzinga
  6. Markets Sell-Off After Malaysian Airline Crash In Ukraine

    Benzinga
  7. Earnings Scheduled For July 17, 2014

    Benzinga
  8. Google's X division

    IBD
  9. Benzinga Weekly Preview: Earnings Season Kicks Into High Gear

    Benzinga
  10. NOVARTIS

    IBD
  11. Novartis Announces Beginning of Shipment of Seasonal Influenza Vaccines ...

    Benzinga
  12. US Stock Futures Edge Higher Ahead Of Consumer Price Index

    Benzinga
  13. IPO Stock Watch: Receptos Soars On MS Drug Results

    IBD
  14. Joseph Papa, A Generic CEO With Brand-Name Action

    IBD
  15. ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects

    Benzinga
  16. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  17. Top Held European Stocks Highlighted by Health Care and Oil and Gas Stocks

    GuruFocus
  18. Two New WisdomTree International ETFs (IHDG, EUDG, BHP, NVS)

    Benzinga
  19. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  20. Can Pfizer Make Up Its Loss?

    GuruFocus
  21. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  22. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  23. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  24. China Rule Change Further Opens Yuan To World Markets

    IBD
  25. These Three Pharmaceutical Companies Shake The Market With Their Deal

    GuruFocus
  26. Drugmakers' Q1 was anemic

    IBD
  27. RBC Optimistic on Regeneron Following Lower Sales by Novartis' Lucentis

    Benzinga
  28. UPDATE: Novartis Posts Rise In Q1 Profit

    Benzinga
  29. Earnings Scheduled For April 24, 2014

    Benzinga
  30. Big Pharmas Swap Specialties

    IBD
  31. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  32. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  33. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  34. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  35. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  36. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
  37. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  38. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  39. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga
  40. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  41. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  42. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  43. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  44. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  45. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  46. PetMed Express Inc. Is Trying Harder to Push Sales

    GuruFocus
  47. Mallinckrodt, Questcor Merger Gets Mixed Reception

    IBD
  48. Trial Results Lift Drug Sector

    IBD
  49. Stock Futures Look Favorable; Legg Mason, Novartis, Climb

    IBD
  50. Market Wrap For March 27: Markets Lower Following Mixed Economic Data

    Benzinga
Trading Center